A new point mutation associated with mitochondrial encephalomyopathy

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Mitochondrial myopathies, including MELAS syndrome, are often linked to point mutations in the mitochondrial tRNA leucine(UUR) gene.
• Maternally inherited mitochondrial diseases result from mutations in the mitochondrial genome.

Observation:

• A novel mutation in the mitochondrial tRNA leucine(UUR) gene was identified in a patient presenting with mitochondrial encephalomyopathy, pigmentary retinopathy, dementia, hypoparathyroidism, and diabetes mellitus.
• This mutation exhibited heteroplasmy in the patient's blood (30%) and muscle (76%), with varying levels in affected and unaffected family members.
• The mutation was absent in healthy controls and other patients with mitochondrial disorders.

Findings:

• The identified mutation is located at a highly conserved position within the tRNA molecule, near the common MELAS-associated mutation at position 3,243.
• Both mutations are situated within a potential transcriptional control region of the mitochondrial genome.
• The mutation's presence in affected individuals and varying levels of heteroplasmy suggest its role in disease pathogenesis.

Implications:

• This discovery broadens the spectrum of mutations in the mitochondrial tRNA leucine(UUR) gene associated with mitochondrial encephalomyopathies.
• It reinforces the hypothesis that mutations within this specific region and other mitochondrial tRNA genes can lead to complex clinical presentations.
• Further research into this mutation could elucidate specific pathomechanisms and inform diagnostic strategies for mitochondrial disorders.